Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens.
The study describes three polymerase chain reaction (PCR) systems for the CVI988 vaccine virus: the meq gene, the MDV BamHI-D/H 132 bp tandem repeat fragment and the MDV-gB gene. Whereas the PCR product of virulent MDV strains and of the CVI988 virus strain with the meq and the 132 bp primer sets differed for the two templates, the MDV-gB PCR products were similar. The sensitivity of the three PCRs was determined for the two templates: the CVI988 DNA was detected up to 2.48 plaque forming units, and a MDV-1 DNA, was amplified with the 132 bp primers up to the 10(-3) DNA dilution, and up to the 10(-2) with the MDV-gB and meq gene primers. As conventional detection for the CVI988 vaccine virus is by tissue culture, the aim was to analyse the feasibility of the molecular detection of the vaccine virus in the vaccinated chick. In two experimental trials employing specific pathogen free and commercial Lohmann chicks, respectively, the vaccine virus replicated to a limited extent; it was detected only in the spleen of up to 60% chicks at 2-4 weeks and in one chick at 3 weeks, respectively. The survey of three commercial Lohmann flocks, kept in biosecurity conditions, revealed the vaccine virus only in the spleen of 40% of 30-day-old chicks. The present study shows that CV1988 DNA is present in vaccinated chicks in a low quantity and it is difficult to detect directly from the chick, probably because vaccine viruses are latent in vivo. For an efficient detection it is pertinent to cultivate the vaccine virus on chicken embryo fibroblasts (CEF), as then the virus escapes the latent state, enters into the productive mode of replication, and a high viral copy number is produced.
Davidson
I
I
Division of Avian and Fish Diseases, Kimron Veterinary Institute, Bet Dagan, Israel. iritd_vs@netvision.net.il
Borenshtain
R
R
Weisman
Y
Y
D000818:Animals; D002645:Chickens / Q000276:immunology* / Q000821:virology*; D017931:DNA Primers; D004279:DNA, Viral / Q000235:genetics / Q000302:isolation & purification*; D007114:Immunization / Q000662:veterinary; D025922:Mardivirus / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D008380:Marek Disease / Q000517:prevention & control / Q000821:virology*; D022501:Marek Disease Vaccines / Q000302:isolation & purification; D016133:Polymerase Chain Reaction / Q000379:methods / Q000592:standards / Q000662:veterinary*; D012680:Sensitivity and Specificity; D013047:Specific Pathogen-Free Organisms; D020080:Tandem Repeat Sequences
D017931:DNA Primers; D004279:DNA, Viral; D022501:Marek Disease Vaccines